701 related articles for article (PubMed ID: 22183160)
1. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities.
Prakash G; Manikandan R; Viswanathamurthi P; Velmurugan K; Nandhakumar R
J Photochem Photobiol B; 2014 Sep; 138():63-74. PubMed ID: 24911273
[TBL] [Abstract][Full Text] [Related]
3. Effect of substitution and planarity of the ligand on DNA/BSA interaction, free radical scavenging and cytotoxicity of diamagnetic Ni(II) complexes: a systematic investigation.
Sathyadevi P; Krishnamoorthy P; Butorac RR; Cowley AH; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2011 Oct; 40(38):9690-702. PubMed ID: 21858314
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes.
Liu YJ; Zeng CH; Huang HL; He LX; Wu FH
Eur J Med Chem; 2010 Feb; 45(2):564-71. PubMed ID: 19932529
[TBL] [Abstract][Full Text] [Related]
5. Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and in vitro anticancer activity.
Sathiya Kamatchi T; Chitrapriya N; Kim SK; Fronczek FR; Natarajan K
Eur J Med Chem; 2013 Jan; 59():253-64. PubMed ID: 23234855
[TBL] [Abstract][Full Text] [Related]
6. Organometallic ruthenium(II) complexes: synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity.
Sathyadevi P; Krishnamoorthy P; Bhuvanesh NS; Kalaiselvi P; Vijaya Padma V; Dharmaraj N
Eur J Med Chem; 2012 Sep; 55():420-31. PubMed ID: 22901409
[TBL] [Abstract][Full Text] [Related]
7. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity.
Liu YJ; Zeng CH; Liang ZH; Yao JH; Huang HL; Li ZZ; Wu FH
Eur J Med Chem; 2010 Jul; 45(7):3087-95. PubMed ID: 20417586
[TBL] [Abstract][Full Text] [Related]
9. Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?
Krishnamoorthy P; Sathyadevi P; Butorac RR; Cowley AH; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2012 Apr; 41(15):4423-36. PubMed ID: 22344370
[TBL] [Abstract][Full Text] [Related]
10. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
Cabrera E; Cerecetto H; González M; Gambino D; Noblia P; Otero L; Parajón-Costa B; Anzellotti A; Sánchez-Delgado R; Azqueta A; López de Ceráin A; Monge A
Eur J Med Chem; 2004 Apr; 39(4):377-82. PubMed ID: 15072846
[TBL] [Abstract][Full Text] [Related]
12. Influence of PPh₃ moiety in the anticancer activity of new organometallic ruthenium complexes.
Sáez R; Lorenzo J; Prieto MJ; Font-Bardia M; Calvet T; Omeñaca N; Vilaseca M; Moreno V
J Inorg Biochem; 2014 Jul; 136():1-12. PubMed ID: 24690555
[TBL] [Abstract][Full Text] [Related]
13. A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.
Raja DS; Bhuvanesh NS; Natarajan K
Dalton Trans; 2012 Apr; 41(15):4365-77. PubMed ID: 22354161
[TBL] [Abstract][Full Text] [Related]
14. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
[TBL] [Abstract][Full Text] [Related]
15. Mixed ligand palladium(II) complexes of 6-methoxy-2-oxo-1,2-dihydroquinoline-3-carbaldehyde 4N-substituted thiosemicarbazones with triphenylphosphine co-ligand: synthesis, crystal structure and biological properties.
Ramachandran E; Senthil Raja D; Bhuvanesh NS; Natarajan K
Dalton Trans; 2012 Nov; 41(43):13308-23. PubMed ID: 22864662
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
17. An investigation on new ruthenium(II) hydrazone complexes as anticancer agents and their interaction with biomolecules.
Alagesan M; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2014 Apr; 43(16):6087-99. PubMed ID: 24519473
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium(II) carbonyl complexes containing pyridine carboxamide ligands and PPh₃/AsPh₃/Py coligands: synthesis, spectral characterization, catalytic and antioxidant studies.
Ramachandran R; Viswanathamurthi P
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():53-61. PubMed ID: 23257330
[TBL] [Abstract][Full Text] [Related]
19. Role of substitution at terminal nitrogen of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the coordination behavior and structure and biological properties of their palladium(II) complexes.
Ramachandran E; Senthil Raja D; Rath NP; Natarajan K
Inorg Chem; 2013 Feb; 52(3):1504-14. PubMed ID: 23323516
[TBL] [Abstract][Full Text] [Related]
20. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
